Coagulogen-free clarified limulus amebocyte lysate
AssigneeLonza Walkersville, Inc.
InventorsCandice Stumbaugh, Leben Tadesse, Karen Lin
Life of this patent
Estimating the term…
Loading patent…
AssigneeLonza Walkersville, Inc.
InventorsCandice Stumbaugh, Leben Tadesse, Karen Lin
Estimating the term…
The present invention is related to compositions comprising clarified limulus amebocyte lysate (LAL), wherein the LAL is substantially free of coagulogen and methods of making such compositions. The invention further relates to a method of detecting an endotoxin in a sample using a chromogenic assay, the method comprising: (a) contacting the sample with a reagent comprising clarified LAL and a chromogenic substrate; and (b) measuring a chromogenic effect resulting from a change in the chromogenic substrate in the presence of endotoxin in the sample, wherein the LAL is substantially free of coagulogen. The invention also relates to kits comprising clarified LAL substantially free of coagulogen, and methods of making such.
A composition comprising clarified limulus amebocyte lysate (LAL) and a detergent, wherein the clarified LAL is LAL that has been (i) filtered using tangential flow filtration with a 20 kDa to 50 kDa filter to remove at least 60% (wt/wt) of its coagulogen such that it comprises less than 10% (wt/wt) of coagulogen relative to total protein in the LAL as measured by SDS-PAGE and protein stain, and then (ii) subjected to centrifugation.
A composition comprising clarified limulus amebocyte lysate (LAL) and a detergent, wherein the clarified LAL comprises less than 5% (wt/wt) of coagulogen relative to total protein in the LAL as measured by SDS-PAGE and protein stain, and wherein the clarified LAL is made by a method comprising:
A kit comprising:
Dependencies are inferred from the claim text.